Published in Am J Respir Crit Care Med on November 15, 2001
Clinical and Biological Markers in Acute Respiratory Failure | NCT02019095
High Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome (ARDS) | NCT01478802
Using GM-CSF as a Host Directed Therapeutic Against COVID-19 | NCT04400929
Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 6.10
Contribution of neutrophils to acute lung injury. Mol Med (2010) 3.59
Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol (2005) 2.93
Into the eye of the cytokine storm. Microbiol Mol Biol Rev (2012) 2.58
Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med (2011) 2.40
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
Essential role of MMP-12 in Fas-induced lung fibrosis. Am J Respir Cell Mol Biol (2007) 2.16
Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J (2006) 1.82
Orthologous gene-expression profiling in multi-species models: search for candidate genes. Genome Biol (2004) 1.77
Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med (2010) 1.70
Innate immunity in the lungs. Proc Am Thorac Soc (2005) 1.66
Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia. Pediatr Crit Care Med (2008) 1.57
Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med (2007) 1.37
Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol (2011) 1.34
IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. J Clin Invest (2013) 1.28
Science review: searching for gene candidates in acute lung injury. Crit Care (2004) 1.27
Differential response of human lung epithelial cells to fas-induced apoptosis. Am J Pathol (2004) 1.27
Gene silencing in severe systemic inflammation. Am J Respir Crit Care Med (2007) 1.27
Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med (2008) 1.26
Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury. Crit Care Clin (2011) 1.23
Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome. Crit Care (2003) 1.23
Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. Am J Respir Crit Care Med (2008) 1.17
Assessment of lung inflammation with 18F-FDG PET during acute lung injury. AJR Am J Roentgenol (2010) 1.17
Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol (2006) 1.16
Biomarkers in acute lung injury. Transl Res (2012) 1.11
Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors. J Immunol (2008) 1.11
Development of animal models for the acute respiratory distress syndrome. Dis Model Mech (2009) 1.10
Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophages. Mol Immunol (2007) 1.08
Lymphocytes in the development of lung inflammation: a role for regulatory CD4+ T cells in indirect pulmonary lung injury. J Immunol (2009) 1.07
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respir Res (2010) 1.06
Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease. Theranostics (2013) 1.06
Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano (2012) 1.04
Exploration of the normal human bronchoalveolar lavage fluid proteome. Proteomics Clin Appl (2008) 0.98
Critical role of PBEF expression in pulmonary cell inflammation and permeability. Cell Biol Int (2008) 0.98
Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1. PLoS One (2013) 0.97
A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury. J Surg Res (2010) 0.96
The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax (2003) 0.95
Biomarkers in acute lung injury--marking forward progress. Crit Care Clin (2011) 0.95
Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury. Thorax (2005) 0.94
Comparison of two non-bronchoscopic methods for evaluating inflammation in patients with acute hypoxaemic respiratory failure. Crit Care (2009) 0.94
Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury. J Biol Chem (2011) 0.93
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome. BMC Pulm Med (2004) 0.92
Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome. Clin Exp Immunol (2013) 0.91
Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis. Inflammation (2004) 0.91
Experimental models and emerging hypotheses for acute lung injury. Crit Care Clin (2011) 0.91
Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability. Inflamm Res (2011) 0.90
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice. Sci Rep (2014) 0.90
Making genomics functional: deciphering the genetics of acute lung injury. Proc Am Thorac Soc (2008) 0.90
Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice. PLoS One (2011) 0.89
Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury. Mucosal Immunol (2013) 0.88
Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array. Mediators Inflamm (2006) 0.87
Valproic acid attenuates lipopolysaccharide-induced acute lung injury in mice. Inflammation (2013) 0.87
Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice. PLoS One (2013) 0.87
Effects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice. Am J Respir Cell Mol Biol (2009) 0.87
Human epidermal growth factor receptor signaling in acute lung injury. Am J Respir Cell Mol Biol (2012) 0.86
Pleiotropic effects of interleukin-6 in a "two-hit" murine model of acute respiratory distress syndrome. Pulm Circ (2014) 0.85
Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res (2005) 0.85
Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies. J Appl Physiol (1985) (2011) 0.84
SIRT1 protects rat lung tissue against severe burn-induced remote ALI by attenuating the apoptosis of PMVECs via p38 MAPK signaling. Sci Rep (2015) 0.84
Augmentation of Pulmonary Epithelial Cell IL-8 Expression and Permeability by Pre-B-cell Colony Enhancing Factor. J Inflamm (Lond) (2008) 0.84
IL-1beta induces an exaggerated pro- and anti-inflammatory response in peritoneal macrophages of children compared with adults. Pediatr Surg Int (2004) 0.82
Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation. J Immunol (2014) 0.82
Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice. PLoS One (2013) 0.82
Pulmonary epithelial barrier function: some new players and mechanisms. Am J Physiol Lung Cell Mol Physiol (2015) 0.82
In vitro exposure of precision-cut lung slices to 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride (NSC 710305, Phortress) increases inflammatory cytokine content and tissue damage. Toxicol Sci (2012) 0.82
Hyperosmolarity invokes distinct anti-inflammatory mechanisms in pulmonary epithelial cells: evidence from signaling and transcription layers. PLoS One (2014) 0.81
Tumor necrosis factor alpha as a marker of systemic and local inflammation in "healthy" smokers. Int J Gen Med (2009) 0.81
Stevioside protects LPS-induced acute lung injury in mice. Inflammation (2013) 0.80
Long-term home noninvasive mechanical ventilation increases systemic inflammatory response in chronic obstructive pulmonary disease: a prospective observational study. Mediators Inflamm (2014) 0.79
Oleic acid induces lung injury in mice through activation of the ERK pathway. Mediators Inflamm (2012) 0.79
Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome. Mediators Inflamm (2012) 0.79
Immunophenotype expressions and cytokine profiles of influenza A H1N1 virus infection in pediatric patients in 2009. Dis Markers (2014) 0.79
Wogonoside ameliorates lipopolysaccharide-induced acute lung injury in mice. Inflammation (2014) 0.79
Measurement of cytokines and adhesion molecules in the first 72 hours after severe trauma: association with severity and outcome. Dis Markers (2015) 0.78
Comparison of recruitment manoeuvres in ventilated sheep with acute respiratory distress syndrome. Lung (2012) 0.78
C1P Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Preventing NF-κB Activation in Neutrophils. J Immunol (2016) 0.78
Exhaled breath profiling for diagnosing acute respiratory distress syndrome. BMC Pulm Med (2014) 0.78
Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS. Br J Pharmacol (2015) 0.78
Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome. Crit Care (2012) 0.78
Corticosteroids and ARDS: A review of treatment and prevention evidence. Lung India (2011) 0.77
LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells. Am J Respir Cell Mol Biol (2013) 0.77
PTEN-Foxo1 signaling triggers HMGB1-mediated innate immune responses in acute lung injury. Immunol Res (2015) 0.77
Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Am J Med Sci (2012) 0.77
TRPV4 Mechanosensitive Ion Channel Regulates Lipopolysaccharide-Stimulated Macrophage Phagocytosis. J Immunol (2015) 0.77
Inflammatory markers in blood and exhaled air after short-term exposure to cooking fumes. Ann Occup Hyg (2012) 0.76
Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation. Thorax (2016) 0.76
Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2011) 0.76
Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury. Crit Care (2016) 0.75
The Omega-3 Fatty Acid Docosahexaenoic Acid Modulates Inflammatory Mediator Release in Human Alveolar Cells Exposed to Bronchoalveolar Lavage Fluid of ARDS Patients. Biomed Res Int (2015) 0.75
Differences of plasma IL-1 and TNF-α in healthy Chinese Population. Open Med (Wars) (2015) 0.75
Effect of hypertonic saline treatment on the inflammatory response after hydrochloric acid-induced lung injury in pigs. Clinics (Sao Paulo) (2015) 0.75
Suppressive oligonucleotides inhibit inflammation in a murine model of mechanical ventilator induced lung injury. J Thorac Dis (2016) 0.75
The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia. BMC Pulm Med (2016) 0.75
The Role of Transient Receptor Potential Vanilloid 4 in Pulmonary Inflammatory Diseases. Front Immunol (2017) 0.75
A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome. Dis Markers (2016) 0.75
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) Is Elevated in Bronchoalveolar Lavage Fluid of Patients with Acute Respiratory Distress Syndrome. PLoS One (2016) 0.75
Biomarkers in Pediatric ARDS: Future Directions. Front Pediatr (2016) 0.75
Alcohol and lung injury and immunity. Alcohol (2016) 0.75
CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats. PLoS One (2017) 0.75
Subcutaneous and mediastinal emphysema. Pathophysiology, diagnosis, and management. Arch Intern Med (1984) 7.78
The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med (1997) 4.98
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood (1996) 4.65
Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int (2006) 4.51
Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med (2000) 3.89
Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest (1998) 3.85
Use of the medical futility rationale in do-not-attempt-resuscitation orders. JAMA (1995) 3.73
Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med (2001) 3.40
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol (2000) 3.37
When life support is questioned early in the care of patients with cervical-level quadriplegia. N Engl J Med (1993) 3.25
Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med (2000) 3.03
Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis (1985) 2.90
Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med (2001) 2.82
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 2.81
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest (1999) 2.67
Clinical predictors of the adult respiratory distress syndrome. Am J Surg (1982) 2.62
Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med (1999) 2.60
Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.57
Interobserver variability in applying a radiographic definition for ARDS. Chest (1999) 2.56
Rationing of intensive care unit services. An everyday occurrence. JAMA (1986) 2.51
Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet (1980) 2.47
Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med (1995) 2.33
Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.33
Active anaphylaxis in IgE-deficient mice. Nature (1994) 2.32
Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med (2001) 2.28
Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med (1997) 2.26
Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol (1999) 2.25
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med (1999) 2.20
Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol (2001) 2.18
Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol (2001) 2.16
beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol (2000) 2.14
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA (1999) 2.12
Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA (1995) 2.12
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis (1992) 2.11
Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest (1991) 2.11
Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med (1997) 2.10
Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest (1989) 2.09
Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med (2000) 2.04
Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A (1997) 1.99
Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med (1994) 1.98
T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat Med (1997) 1.94
Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med (1996) 1.88
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest (1989) 1.88
The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am Rev Respir Dis (1991) 1.81
Association of low birth weight with passive smoke exposure in pregnancy. Am J Epidemiol (1986) 1.80
Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med (1999) 1.77
Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. Crit Care Med (1999) 1.77
Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis (1989) 1.75
Outcome after hemorrhagic shock in trauma patients. J Trauma (1998) 1.72
Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat Genet (1995) 1.70
Cloning and expression of a viral phosphoprotein: structure suggests vesicular stomatitis virus NS may function by mimicking an RNA template. J Gen Virol (1986) 1.66
Epidemiology of acute lung injury and ARDS. Chest (1999) 1.65
Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein. Am J Hum Genet (1989) 1.64
Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax (1994) 1.63
Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation (2001) 1.61
Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol (1991) 1.54
Accidental hypothermia. Associated diagnoses and prognosis in a common problem. JAMA (1974) 1.52
Impaired peripheral chemosensitivity and acute respiratory failure in Arnold-Chiari malformation and syringomyelia. N Engl J Med (1973) 1.49
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol (2000) 1.48
The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure. Chest (1982) 1.48
Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med (1997) 1.48
Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis. Eur J Clin Microbiol Infect Dis (2005) 1.47
Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis (1984) 1.45
Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism. Am J Respir Crit Care Med (2001) 1.45
Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol (1998) 1.45
Rapid fluorescence-based measurement of neutrophil migration in vitro. J Immunol Methods (1998) 1.44
Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am J Physiol (1999) 1.42
Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system. J Neurosci Res (1997) 1.42
The pulmonary academic "transitional track". How do we get them out of the nest? Am Rev Respir Dis (1989) 1.39
Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol (1999) 1.38